Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weinstein

Showing results (411-420 of 611) with videos related to

Pageof 62
Sort By:
Trials|January 23, 2021
STeroids Against Radiculopathy (STAR) trial: a statistical analysis planBastiaan C Ter Meulen, Johanna M van Dongen, Marinus van der Vegt, et al.
Pharmacoeconomics|April 16, 2013
Cost effectiveness of targeted high-dose atorvastatin therapy following genotype testing in patients with acute coronary syndromeAnju Parthan, Kevin J Leahy, Amy K O'Sullivan, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1981
Coronary artery bypass graft surgery: clinical decision making and cost-effectiveness analysisJ S Pliskin, W B Stason, M C Weinstein, et al.
JAMA|January 24, 1998
The cost-effectiveness of preventing AIDS-related opportunistic infectionsK A Freedberg, J A Scharfstein, G R Seage, et al.
Circulation|January 7, 1997
Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levelsA N Tosteson, M C Weinstein, M G Hunink, et al.
The American Journal of Managed Care|January 13, 2006
Do drug formulary policies reflect evidence of value?Peter J Neumann, Pei-Jung Lin, Dan Greenberg, et al.
Dementia and Geriatric Cognitive Disorders|February 18, 2006
The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complexB van Harten, D M Laman, H van Duijn, et al.
Substance Abuse Treatment, Prevention, and Policy|January 14, 2023
Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment programMegan K Reed, Kelsey R Smith, Francesca Ciocco, et al.
Early Human Development|February 14, 2006
Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infantsJohn A F Zupancic, Douglas K Richardson, Bernie J O'Brien, et al.
Circulation|April 1, 1994
Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic modelD J Cohen, J A Breall, K K Ho, et al.
Pageof 62

Showing results (411-420 of 611) with videos related to

Sort By:
Pageof 62
Trials|January 23, 2021
STeroids Against Radiculopathy (STAR) trial: a statistical analysis planBastiaan C Ter Meulen, Johanna M van Dongen, Marinus van der Vegt, et al.
Pharmacoeconomics|April 16, 2013
Cost effectiveness of targeted high-dose atorvastatin therapy following genotype testing in patients with acute coronary syndromeAnju Parthan, Kevin J Leahy, Amy K O'Sullivan, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1981
Coronary artery bypass graft surgery: clinical decision making and cost-effectiveness analysisJ S Pliskin, W B Stason, M C Weinstein, et al.
JAMA|January 24, 1998
The cost-effectiveness of preventing AIDS-related opportunistic infectionsK A Freedberg, J A Scharfstein, G R Seage, et al.
Circulation|January 7, 1997
Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levelsA N Tosteson, M C Weinstein, M G Hunink, et al.
The American Journal of Managed Care|January 13, 2006
Do drug formulary policies reflect evidence of value?Peter J Neumann, Pei-Jung Lin, Dan Greenberg, et al.
Dementia and Geriatric Cognitive Disorders|February 18, 2006
The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complexB van Harten, D M Laman, H van Duijn, et al.
Substance Abuse Treatment, Prevention, and Policy|January 14, 2023
Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment programMegan K Reed, Kelsey R Smith, Francesca Ciocco, et al.
Early Human Development|February 14, 2006
Retrospective economic evaluation of a controlled trial of indomethacin prophylaxis for patent ductus arteriosus in premature infantsJohn A F Zupancic, Douglas K Richardson, Bernie J O'Brien, et al.
Circulation|April 1, 1994
Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic modelD J Cohen, J A Breall, K K Ho, et al.
Pageof 62